Brilliant blue G

DB15594ApprovedSmall moleculeDisclosing Agent

Brilliant blue G is a disclosing agent used in ophthalmological surgery to stain the internal limiting membrane (ILM). This membrane is thin and translucent, making it difficult to identify during eye surgeries that require high levels of visual accuracy.

Chemical structure of Brilliant blue G
Mechanism
Curator reviewed · 5 references
Primary indication
This drug is indicated for selectively staining the internal limiting membrane (ILM).Curator reviewed · 1 structured indication
Formula / weight
C47H48N3NaO7S2 · 854.02 g/mol (avg)
First approval
Canada, 2021 · United States, 2019
Also known as
Acid Blue 90 · C.I. Acid Blue 90 · Coomassie Brilliant Blue G
Code names
BBG-250

Resolves to

Clinical / RWD
Structure
InChIKeyRWVGQQGBQSJDQV-UHFFFAOYSA-MSMILES[Na+].CCOC1=CC=C(NC2=CC=C(C=C2)C(=C2\C=C/C(/C=C2C)=[N+](/CC)CC2=CC(=CC=C2)S([O-])(=O)=O)\C2=C(C)C=C(C=C2)N(CC)CC2=CC(=CC=C2)S([O-])(=O)=O)C=C1

What you can answer from here — as of August 05, 2021

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2Marketed productsAcross 2 countries and 2 labellers
Sign in
12+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Brilliant blue G, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account